New York State Common Retirement Fund Galectin Therapeutics Inc Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,600 shares of GALT stock, worth $26,081. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,600
Previous 45,500
72.31%
Holding current value
$26,081
Previous $103,000
66.02%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GALT
# of Institutions
91Shares Held
9.65MCall Options Held
1.16MPut Options Held
1.98M-
Vanguard Group Inc Valley Forge, PA2.13MShares$4.42 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$3.24 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$2.45 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA863KShares$1.79 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$1 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $123M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...